HYALURONIC ACID SODIUM SALT 1% / NIACINAMIDE 4% / TACROLIMUS 0.1%
HYALURONIC ACID SODIUM SALT 1% / NIACINAMIDE 4% / TACROLIMUS 0.1%
Approved
Approval ID
874bbbd4-1244-2867-e053-2995a90a8593
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Apr 24, 2019
Manufacturers
FDA
Sinceru Florida, LLC
DUNS: 080105003
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
HYALURONIC ACID SODIUM SALT 1% / NIACINAMIDE 4% / TACROLIMUS 0.1%
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code72934-2096
Product Classification
G
Generic Name
HYALURONIC ACID SODIUM SALT 1% / NIACINAMIDE 4% / TACROLIMUS 0.1%
Product Specifications
Route of AdministrationTOPICAL
Effective DateApril 24, 2019
FDA Product Classification
INGREDIENTS (3)
TACROLIMUSActive
Quantity: 0.1 g in 100 g
Code: WM0HAQ4WNM
Classification: ACTIM
HYALURONIC ACIDActive
Quantity: 1 g in 100 g
Code: S270N0TRQY
Classification: ACTIB
NIACINAMIDEActive
Quantity: 4 g in 100 g
Code: 25X51I8RD4
Classification: ACTIB